Premium
Safety during crisis: Rapid on‐site evaluation at the time of COVID ‐19 pandemic
Author(s) -
Asiry Saeed,
Fatyan Alaaeddin,
Matloob Ammar,
Khader Samer N.
Publication year - 2020
Publication title -
diagnostic cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 65
eISSN - 1097-0339
pISSN - 8755-1039
DOI - 10.1002/dc.24453
Subject(s) - medicine , pandemic , covid-19 , cytopathology , personal protective equipment , safer , virology , infection control , medical emergency , environmental health , intensive care medicine , infectious disease (medical specialty) , pathology , computer security , disease , cytology , outbreak , computer science
The COVID‐19 pandemic is posing a worldwide challenge to control and contain. SARS‐CoV‐2 is a highly infectious virus. Health care providers at the front lines are at high risk of getting the infection and the risk applies also to laboratory personnel as they deal with specimens that might be contaminated with infectious materiel. Cytopathology teams specifically are at high risk of dealing with contaminated material because of patients encounter during fine‐needle aspiration biopsies or Rapid On‐Site Evaluation (ROSE) for adequacy. In our article, we discuss alternative safer staining methods to the widely used Diff–Quick stain that can be utilized for ROSE to decrease the risk of viral exposure during the current COVID‐19 pandemic.